000			02212cam a2200349 a 4500
003			EG-GiCUC
005			20250223031237.0
008			150609s2014 ua d f m 000 0 eng d
040			_aEG-GiCUC _beng _cEG-GiCUC
041	0		_aeng
049			_aDeposite
097			_aPh.D
099			_aCai01.19.05.Ph.D.2014.Mo.M
100	0		_aMoatasem Mohamed Hatem Elayadi
245	1	0	_aManagement and outcome of newly diagnosed wilms{u2019} tumor at National Cancer Institute Cairo University and Children Cancer Hospital, Egypt / _cMoatasem Mohamed Hatem Elayadi ; Supervised Emad Nabil Ebeid , Mohamed Saad Zaghloul , Alaa Abdelhamid Younes
246	1	5	_aالمعالجة والنتائج لحالات أورام الكلى (أورام ويلمز) حديثة التشخيص بالمعهد القومى للأورام : جامعة القاهرة ومستشفى سرطان الأطفال : مصر
260			_aCairo : _bMoatasem Mohamed Hatem Elayadi , _c2014
300			_a125 P. : _bcharts ; _c25cm
502			_aThesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Pediatric Oncology
520			_aOur study aimed at evaluating the demographics, disease characteristics and treatment outcome for unilateral WT patients treated at National Cancer Institute, Cairo University and Children Cancer Hospital, Egypt (57357). This cohort study included 135 eligible patients with newly diagnosed nephroblastoma during the period from January 2010 to December 2011. The median follow up period was 29.3 months (range 0.3 to 46.6 months). Our results concluded that outcome of unilateral WT is generally good for early stages and comparable to results from other groups. Metastatic state at presentation was associated with significant reduction in OS and EFS rates
530			_aIssued also as CD
653		4	_aPaediatric Oncology
653		4	_aRenal Tumors
653		4	_aSurvival Rates
700	0		_aAlaa Abdelhamid Younes , _eSupervisor
700	0		_aEmad Nabil Ebeid , _eSupervisor
700	0		_aMohamed Saad Zaghloul , _eSupervisor
856			_uhttp://172.23.153.220/th.pdf
905			_aNazla _eRevisor
905			_aSoheir _eCataloger
942			_2ddc _cTH
999			_c51268 _d51268